Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

335
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
335

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mandarin speech-based early detection of SCD: a feature-fusion residual network method.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

CPI-MIF: Compound-Protein Interaction Prediction with Multiview Information Fusion.

ACS omega·2025
Same author

Identifying New Risk Associations Between Chronic Physical Illness and Mental Health Disorders in China: Machine Learning Approach to a Retrospective Population Analysis.

JMIR AI·2025
Same author

SDDSynergy: Learning Important Molecular Substructures for Explainable Anticancer Drug Synergy Prediction.

Journal of chemical information and modeling·2024
Same author

RDFNet: A Fast Caries Detection Method Incorporating Transformer Mechanism.

Computational and mathematical methods in medicine·2021
Same author

Enriching limited information on rare diseases from heterogeneous networks for drug repositioning.

BMC medical informatics and decision making·2021

Related Experiment Video

Updated: Jan 16, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

905

Heterogeneous Network With Multiview Path Aggregation: Drug-Target Interaction Prediction Study Design.

Haixue Zhao1,2, Kui Yao1, Yunjiong Liu3,4,5

  • 1Key Laboratory of Advanced Design and Intelligent Computing, Ministry of Education, Dalian University, Dalian, China.

JMIR Medical Informatics
|October 2, 2025
PubMed
Summary

This study introduces a novel heterogeneous network model for drug-target interaction (DTI) prediction, significantly improving accuracy and interpretability. The model effectively integrates diverse biological data, outperforming existing methods in identifying potential drug-target relationships.

Keywords:
drug repurposingdrug-target interactionsgraph neural networksheterogeneous networks

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

Related Experiment Videos

Last Updated: Jan 16, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

905
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

Area of Science:

  • Computational Biology
  • Drug Discovery
  • Bioinformatics

Background:

  • Drug-target interaction (DTI) prediction is vital for drug repositioning, reducing R&D costs.
  • Current deep learning methods, often using graph neural networks, struggle with complex biochemical features and interpretability.

Purpose of the Study:

  • To develop an advanced heterogeneous network model for accurate DTI prediction.
  • To enhance the integration of multilevel biological information and model interpretability.

Main Methods:

  • Utilized a molecular attention transformer for drug 3D conformation features and Prot-T5 for protein sequence features.
  • Constructed a heterogeneous graph integrating drugs, proteins, diseases, and side effects.
  • Implemented a multiview path aggregation mechanism for dynamic information integration.

Main Results:

  • Achieved an AUPR of 0.901 and AUROC of 0.966 in DTI prediction, surpassing baseline methods.
  • Demonstrated practical utility with a case study predicting interactions for the KCNH2 target.

Conclusions:

  • The proposed model exhibits superior performance over baseline methods.
  • Integrating heterogeneous data with biological knowledge is crucial for effective DTI prediction.